Mylan Pharmaceuticals Inc recalls Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 m
Recalled January 26, 2022 · FDA recall D-0462-2022 · Mylan Pharmaceuticals
Hazard
Labeling: Missing Label: label missing from some Semglee prefilled pens. · FDA Class I
Units
73,175 prefilled pens
Sold at
Nationwide in the USA and Thailand.
Description
Labeling: Missing Label: label missing from some Semglee prefilled pens.
Product
Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled Pens per carton (NDC 49502-0196-75), Rx only, Manufactured in Malaysia for: Mylan Specialty L.P., Morgantown, WV, 26505.
Manufacturer(s)
Mylan Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →